Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis.

Wenfa HuangRan RanBin ShaoHuiping Li

Published in: Breast cancer research and treatment (2019)

PD-L1 expression on TCs associates with high-risk clinicopathological parameters and poor prognosis in PBC patients, while PD-L1+ TILs may relate to a better survival. Comprehensive assessment of TCs and TILs is required when evaluating the clinical relevance of PD-L1 expression in future studies.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
ejection fraction
newly diagnosed
patient reported outcomes